Both in Pharmaceuticals
Gyre Therapeutics vs Aquestive Therapeutics
Over the past year GYRE returned −39.6% and AQST returned −38.9%; their daily moves had a correlation of 0.16.
GYRE −39.6% AQST −38.9%Growth of $1, one year, split-adjusted
| Metric | GYRE | AQST |
|---|---|---|
| Price | $4.45 | $3.97 |
| Market cap | $471.3M | $497.7M |
| Today | +0.11% | +2.19% |
| 1 month | −37.2% | −14.0% |
| 6 months | −44.7% | −6.3% |
| Year to date | −37.0% | −38.6% |
| 1 year | −39.6% | −38.9% |
| Revenue growth (YoY) | −2.1% | +38.1% |
| Gross margin | 92.4% | 70.9% |
| Net margin | −40.1% | −165.5% |
| P/E (TTM) | — | — |
| Price / sales | 3.9× | 9.2× |
| Net cash | $74.8M | $47.8M |
| Dividend yield | — | — |
| Volatility (60d) | 88.3% | 54.2% |
| Short % of float | 11.5% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).